Minimally invasive drainage implantation device for ophthalmology department
By using the diversion positioning end, marking support ring, stable discharge end and main control in the ophthalmic minimally invasive drainage implantation device, the problem of instability in the intraocular pressure in the prior art is solved. Improves the accuracy of the surgery and patient comfort, reducing the risk of complications.
Patent Information
- Application Number
- CN202411268481.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-11
- Publication Date
- 2024-11-29
AI Technical Summary
The existing ophthalmic drainage tubes are difficult to simulate natural aquaculture flow, resulting in instability of intraocular pressure, increasing side effects and risk of use.
A minimally invasive ophthalmic drainage implantation device is designed, including a diversion positioning end, a marking support ring, a stable discharge end and a main control. The drainage speed and pressure are monitored and adjusted in real time through pressure sensors and flow sensors to ensure accurate control of the drainage effect. .
It improves the accuracy and success rate of the surgery, optimizes the level of vision recovery, reduces the risk of discomfort and complications in patients, extends the service life of the device, and reduces medical costs.
Smart Images

Figure CN119033530A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of medical devices, and in particular to an ophthalmic minimally invasive drainage implantation device. Background Art
[0002] Glaucoma is a group of irreversible blinding eye diseases characterized by pathological high intraocular pressure, visual field loss, optic disc retraction, atrophy and decreased vision. It is one of the three major blinding eye diseases that cause blindness in humans. The cause of glaucoma is the obstruction of aqueous humor circulation, which leads to increased intraocular pressure. The increased intraocular pressure causes optic nerve damage through two mechanisms: mechanical compression and optic nerve ischemia, which mainly manifests as visual field loss, decreased vision and optic disc atrophy. The intraocular cavity can be divided into the anterior chamber, posterior chamber and vitreous cavity. The anterior chamber and posterior chamber are roughly separated by the ciliary body. The aqueous humor is produced by the ciliary body and reaches the posterior chamber, then reaches the anterior chamber through the pupil, and returns to the blood vessels at the anterior chamber angle through the trabecular meshwork to complete the "aqueous humor circulation". Aqueous humor is an important material for maintaining intraocular pressure. Any obstruction in the circulation of aqueous humor will lead to increased intraocular pressure. Clinically, most glaucoma is caused by increased resistance to aqueous humor outflow, such as narrow or even closed anterior chamber angle, trabecular sclerosis, etc. A few are caused by excessive secretion of aqueous humor.
[0003] Patent document with publication number CN110507477A discloses a device for implanting an ophthalmic drainage tube, including a needle assembly and a pushing assembly, wherein the needle assembly includes a needle seat and a puncture needle, a glue dispensing groove is provided at the top of the needle seat, the puncture needle is inserted from the top of the needle seat, passes through the glue dispensing groove and is fixed to the top of the needle seat, and a connecting hole and a connecting tube are sequentially provided at the position where the needle seat contacts the puncture needle; the pushing assembly includes a sleeve movably connected to the end of the needle seat and a push rod penetrated in the sleeve, a sliding groove is provided in the sleeve, the sliding groove and the connecting tube in the needle seat are interconnected, and a push pin is provided at one end of the push rod penetrated in the sleeve, and the push pin and the connecting hole are matched in size.
[0004] Currently, existing drainage tubes have the problem of being difficult to simulate the flow of natural aqueous humor, which leads to their improper use and inability to stabilize intraocular pressure, increasing their side effects and risks of use. Summary of the invention
[0005] To this end, the present invention provides an ophthalmic minimally invasive drainage implant device to overcome the problem in the prior art that it is difficult for aqueous humor drainage implants to simulate the flow of natural aqueous humor, and improper use may lead to unstable intraocular pressure, resulting in large side effects and high risks. A new drainage tube structure, drainage pathway, and a new minimally invasive surgical implantation method and implantation position are provided. The drainage device has an intraocular pressure regulation function and can be accurately positioned. The operation is simple and quick, with low risk and small side effects.
[0006] To achieve the above-mentioned object, the present invention provides an ophthalmic minimally invasive drainage implant device, comprising a drainage positioning end, an identification support ring, a stable discharge end, a drainage cavity and a main control unit; The diversion positioning end has a head provided with a positioning groove, a pressure sensor for monitoring pressure, and a flow sensor for monitoring flow, and the positioning groove is used to locate the head position of the diversion positioning end; The identification support ring is located below the positioning groove and embedded in the groove wall, and is used to support the shape of the tube orifice and determine the position of the tube orifice during implantation; The stable discharge end has a plurality of retaining rings symmetrically arranged on the top and bottom thereof, and the retaining rings are used to fix the position of the drainage tube; The main control is arranged on the stable discharge end, and the main control can obtain the real-time flow of the flow sensor and the real-time pressure of the pressure sensor and make a judgment; when it is judged that the real-time flow is less than or equal to the standard flow and the real-time pressure is less than or equal to the standard pressure, the current drainage speed is maintained; when it is judged that the real-time flow is greater than the standard flow, the drainage speed of the drainage cavity is adjusted to the corrected drainage speed; The drainage cavity is horizontally arranged at the center of the stable discharge end, and is symmetrically provided with inner wall ring grooves matching the number of the retaining rings. The inner wall ring grooves regulate the back pressure by regulating the drainage speed.
[0007] Furthermore, the flow guiding and positioning end further comprises a flap valve arranged inside the flow guiding and positioning end, a cross or straight opening is arranged on the top of the flap valve, and a bottom diameter of the flap valve is larger than a top diameter of the flap valve.
[0008] Furthermore, the identification support ring is configured as a ring-shaped object or a woven mesh object having a fluorescent color system.
[0009] Furthermore, when the main control determines that the real-time pressure is greater than the standard pressure, the main control controls the drainage chamber to drain at a preset drainage speed, and repeats the above process of obtaining the real-time flow and the real-time pressure of the diversion positioning end, and making a judgment based on the standard pressure and the real-time pressure. If it is determined that the real-time pressure is less than or equal to the standard pressure, the main control controls the drainage chamber to maintain the current drainage speed.
[0010] Furthermore, when the main control determines that the real-time flow rate is greater than the standard flow rate, the main control obtains the real-time drainage speed of the drainage cavity, and the main control adjusts the real-time drainage speed according to the real-time flow rate to obtain a corrected drainage speed, wherein Q'=Q×[1-(C-C1) / C], Q' is the corrected drainage speed, Q is the real-time drainage speed of the drainage cavity obtained, C is the real-time flow obtained by the flow sensor, and C1 represents the set standard flow rate.
[0011] Furthermore, the preset curvature of the stable discharge end makes the curvature of the stable discharge end the same as the curvature of the eye.
[0012] Furthermore, one end of the drainage cavity is connected to the diversion positioning end, and a first inner wall ring groove, a second inner wall ring groove, a third inner wall ring groove, a fourth inner wall ring groove and a fifth inner wall ring groove are sequentially arranged, and the spacing between each inner wall ring groove and the depth of each inner wall ring groove can be adjusted to control the back pressure by adjusting the drainage speed.
[0013] Furthermore, the outer wall of the stable discharge end is also provided with a plurality of drug-carrying micropores, and the pores of the drug-carrying micropores are circular, square or polygonal.
[0014] Furthermore, the drug-loaded micropore cooperates with the inner wall annular groove, and the drainage speed is adjusted by changing the cooperation state, wherein the drug-loaded micropore runs through the stable discharge end and is used to assist in the sustained release of the drug loaded therein, and the inner wall annular groove is used to interact with the drug-loaded micropore to adjust the release rate and drainage speed of the drug.
[0015] Furthermore, it also includes cooperation with a delivery device, the delivery device has a built-in puncture needle and an ejector pin, and the drainage cavity is provided with a lining core.
[0016] Compared with the prior art, the beneficial effect of the present invention is that the positioning groove of the drainage positioning end can ensure that the drainage tube head is accurately positioned at the corneal limbus during the implantation process, avoiding displacement and dislocation, thereby improving the accuracy and success rate of the operation. By integrating the pressure sensor and the flow sensor, the main control can monitor the pressure and flow in the drainage cavity in real time, and accurately control it according to the set standard flow to ensure the drainage effect. By maintaining a stable drainage speed and pressure, it helps to optimize the surgical results and improve the patient's vision recovery level. The stable drainage speed reduces the patient's discomfort and improves the patient's overall comfort. The retaining ring of the stable discharge end can fix the position of the drainage tube to prevent it from shifting or falling off, thereby enhancing the stability and reliability of the device. The design of the inner wall groove of the drainage cavity allows the back pressure to be flexibly adjusted after implantation according to the specific needs of the patient and changes in the treatment process to meet the treatment needs of different patients. Through the regulation of the inner wall groove, the drainage efficiency can be optimized and low intraocular pressure can be avoided, thereby improving the efficiency and effect of the treatment.
[0017] In particular, the design of the flap valve can control the drainage speed of the aqueous humor, avoiding low intraocular pressure caused by too fast drainage or too high intraocular pressure caused by too slow drainage. It can also reduce complications caused by displacement or detachment of the drainage tube, thereby extending the service life of the minimally invasive ophthalmic drainage implant device.
[0018] In particular, fluorescent marking makes the surgery more precise and reduces the risk of patients undergoing secondary surgery because the drainage tube can be placed and confirmed more accurately. Fluorescent marking makes it easier to identify and locate the entrance of the drainage tube during surgery, simplifying the surgical steps and reducing the surgical time.
[0019] In particular, by real-time monitoring and adjusting the drainage pressure, it is possible to ensure that the drainage process is carried out efficiently and avoid excessive fluid accumulation or too rapid fluid outflow. Too high pressure may cause damage to intraocular tissue, while too low pressure may lead to poor drainage. Real-time adjustment can avoid these risks and reduce the occurrence of complications. By maintaining a stable drainage speed, the intraocular pressure can be kept stable.
[0020] In particular, when the real-time flow rate exceeds the standard flow rate, the main control will reduce the drainage speed to prevent intraocular fluid accumulation or excessive drainage, thereby reducing the risk of complications. Accurately controlling the drainage speed helps optimize surgical results, reduce postoperative complications, and improve patients' visual recovery. By improving surgical efficiency and reducing complications, medical costs can be reduced. A stable drainage speed can reduce patient discomfort and improve the patient's overall comfort.
[0021] In particular, the stable discharge end matches the curvature of the eye, reducing discomfort during the implantation process and the pressure on the patient's eyes after implantation, thereby improving the patient's comfort.
[0022] In particular, one end of the drainage cavity is connected to the diversion positioning end, and by setting a plurality of inner wall grooves, the drainage speed can be accurately controlled, thereby achieving accurate control of the back pressure. The first inner wall groove to the fifth inner wall groove are arranged in sequence from far to near, which can gradually reduce the drainage speed and then reduce the back pressure, which helps to adapt to different drainage needs and improve the user experience. The more inner wall grooves there are and the greater the depth, the better the effect of reducing the flow rate, which can meet the needs of patients with different degrees of glaucoma. The spacing and depth between each inner wall groove can be adjusted, providing greater flexibility, allowing doctors to adjust according to the patient's specific situation and drainage effect to achieve the best drainage effect. By adjusting the spacing and depth of the inner wall grooves, the drainage speed can be effectively controlled to avoid complications caused by too fast or too slow drainage, such as hypotension or electrolyte imbalance caused by excessive drainage. The design of the inner wall groove helps to reduce the friction and resistance of the drainage tube, reduce the risk of clogging of the drainage tube, and extend the service life of the drainage tube.
[0023] In particular, the shape, size and distribution of drug-loaded micropores can precisely control the release rate and duration of drugs, making drug release more stable and predictable. Through local administration, drugs can act directly on the lesion site, improve treatment efficiency and accelerate the recovery process. The shape of drug-loaded micropores can be circular, square or polygonal, providing more design options and flexibility to accommodate different drugs and treatment needs.
[0024] In particular, by changing the matching state of the drug-carrying micropores and the inner wall annular grooves, the drainage speed can be adjusted to achieve the purpose of treating glaucoma or other eye diseases.
[0025] In particular, the detachability of the ejector pin and the liner makes the drainage tube more flexible during implantation. The doctor can easily adjust the position of the drainage tube according to the specific circumstances of the operation to ensure that it accurately reaches the expected drainage area. The detachable design allows for more precise control of the implantation depth and direction of the drainage tube, thereby reducing the risk of damaging surrounding tissues and reducing the occurrence of complications. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 A cross-sectional schematic diagram of an ophthalmic minimally invasive drainage implant device provided by an embodiment of the present invention; Figure 2 A schematic diagram of the structure of an ophthalmic minimally invasive drainage implant device provided by an embodiment of the present invention; Figure 3 A schematic diagram of the structure of the drug-carrying micropores in the ophthalmic minimally invasive drainage implant device provided by an embodiment of the present invention; Figure 4 A schematic cross-sectional view of a drug-carrying micropore in an ophthalmic minimally invasive drainage implant device provided by an embodiment of the present invention; Figure 5 A schematic diagram of the structure of the drainage cavity in the ophthalmic minimally invasive drainage implant device provided in an embodiment of the present invention.
[0027] Figure markings: 1. diversion positioning end; 11. positioning groove; 12. pressure sensor; 13. flow sensor; 14. flap valve; 2. identification support ring; 3. stable discharge end; 31. retaining ring; 4. drainage cavity; 41. internal ring groove; 42. ejector pin; 43. liner core; 5. main control unit; 6. drug-carrying micropore. DETAILED DESCRIPTION
[0028] In order to make the objects and advantages of the present invention more clearly understood, the present invention is further described below in conjunction with embodiments; it should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0029] The preferred embodiments of the present invention are described below with reference to the accompanying drawings. It should be understood by those skilled in the art that these embodiments are only used to explain the technical principles of the present invention and are not intended to limit the protection scope of the present invention.
[0030] It should be noted that, in the description of the present invention, terms such as "up", "down", "left", "right", "inside" and "outside" indicating directions or positional relationships are based on the directions or positional relationships shown in the drawings. This is merely for the convenience of description and does not indicate or imply that the device or element must have a specific orientation, be constructed and operated in a specific orientation. Therefore, it cannot be understood as a limitation on the present invention.
[0031] In addition, it should be noted that in the description of the present invention, unless otherwise clearly specified and limited, the terms "installed", "connected", and "connected" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or it can be indirectly connected through an intermediate medium, or it can be the internal communication of two components. For those skilled in the art, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.
[0032] See also Figure 1 and Figure 2 As shown, an embodiment of the present invention provides an ophthalmic minimally invasive drainage implant device, including a drainage positioning end 1, an identification support ring 2, a stable discharge end 3, a drainage cavity 4 and a main control 5; The diversion positioning end 1 has a positioning groove 11, a pressure sensor 12 for monitoring pressure, and a flow sensor 13 for monitoring flow, at its head, and the positioning groove is used to locate the head position of the diversion positioning end; See also Figure 1 The ophthalmic minimally invasive drainage implant device described in this embodiment is a cylindrical structure with a pipe mouth on the end face, and the pipe mouth is connected to the drainage cavity 4 inside it. The ophthalmic minimally invasive drainage implant device is divided into a diversion positioning end 1 and a stable discharge end 3. The diameter of the cylindrical structure of the stable discharge end 3 is slightly larger than the diameter of the cylindrical structure of the diversion positioning end 1. The side wall of the diversion positioning end 1 is recessed inward to form a surrounding positioning groove 11. The identification support ring 2 is arranged in the annular positioning groove 11. The identification support ring 2 is made of a hard material. When the diversion positioning end 1 is deformed during implantation, the identification support ring 2 maintains the annular shape without deformation, thereby supporting the stable discharge end 3 so that it is partially non-deformed, and the pipe mouth will not be squeezed and closed, which is convenient for users to determine the position of the pipe mouth during implantation; A plurality of retaining rings 31 are provided at intervals on the outer wall of the stable discharge end 3, and the plurality of retaining rings 31 are all made of hard material, so that the retaining rings 31 can fix the stable discharge end 3 to the patient's eye during the implantation process; The main control 5 is arranged on the stable discharge end 3, and the main control 5 can obtain the real-time flow of the flow sensor and the real-time pressure of the pressure sensor and make a judgment; when it is judged that the real-time flow is less than or equal to the standard flow and the real-time pressure is less than or equal to the standard pressure, the current drainage speed is maintained; when it is judged that the real-time flow is greater than the standard flow, the drainage speed of the drainage cavity is adjusted to the corrected drainage speed; The drainage chamber 4 is horizontally arranged at the center of the stable discharge end, and the drainage chamber 4 also protrudes outward at the protrusion where the retaining ring 31 is arranged, thereby forming an inner wall ring groove 41 matching the retaining ring 31, and the inner wall ring groove is used to adjust the back pressure by adjusting its drainage speed.
[0033] In this embodiment, the specification of the drainage tube is 4-6mm in length, preferably 4.5mm; the outer diameter is 0.3-0.6mm, specifically 0.35-0.4mm which can be determined according to the actual situation of the patient; the inner diameter is 0.05-0.2mm, specifically 0.10-0.16mm which can be determined according to the actual situation of the patient. Among them: the diversion positioning end is 1.0-1.5mm in length, wherein the length extending out of the patient's anterior chamber is 0.4-0.6mm, the positioning groove is 0.5-0.8mm in length, and the groove depth is 0.01-0.05mm; the stable discharge end is 3.0-3.5mm in length, and the retaining rings can be set to 3-6, with an interval of 0.5-1.0mm to prevent displacement, and the ring groove can be set and matched with the retaining ring; the embedded identification support ring is 0.5-0.8mm in length and 0.02-0.05mm in thickness.
[0034] Specifically, the positioning groove of the diversion positioning end can ensure that the drainage tube head is accurately positioned at the corneal limbus during the implantation process, avoiding displacement and dislocation, thereby improving the accuracy and success rate of the operation. By integrating the pressure sensor and the flow sensor, the main control can monitor the pressure and flow in the drainage cavity in real time, and accurately control it according to the set standard flow to ensure the drainage effect. By maintaining a stable drainage speed and pressure, it helps to optimize the surgical results and improve the patient's vision recovery level. The stable drainage speed reduces the patient's discomfort and improves the patient's overall comfort. The retaining ring of the stable discharge end can fix the position of the drainage tube to prevent it from shifting or falling off, thereby enhancing the stability and reliability of the device. The design of the inner wall groove of the drainage cavity allows the back pressure to be flexibly adjusted after implantation according to the specific needs of the patient and changes during the treatment process to meet the treatment needs of different patients. Through the regulation of the inner wall groove, the drainage efficiency can be optimized and low intraocular pressure can be avoided, thereby improving the efficiency and effect of the treatment.
[0035] Specifically, the flow guiding and positioning end further comprises a flap valve 14 arranged inside the flow guiding and positioning end, a cross or straight opening is arranged at the top of the flap valve 14 , and a bottom diameter of the flap valve 14 is larger than a top diameter of the flap valve 14 .
[0036] In this embodiment, the main part of the flap valve 14 is designed as a conical structure, and the bottom diameter is larger than the top diameter to increase the resistance to the flow of aqueous humor. At the top of the flap valve 14, a cross-shaped or straight-shaped opening is designed. When the aqueous humor pressure is high, the aqueous humor can flow out through the top opening due to the limitation of the conical structure; when the aqueous humor pressure is low, the top opening will be closed to prevent the aqueous humor from flowing back. According to the number and thickness of the flaps, the threshold value of the flap valve 14 can be adjusted to achieve the function of regulating intraocular pressure. By changing the number and thickness of the flaps, the size of the top opening can be adjusted, thereby changing the resistance to the flow of aqueous humor and then regulating intraocular pressure. The flap valve 14 can be manufactured by integral injection molding to ensure the integrity and consistency of the flap valve 14. This manufacturing method can also ensure the durability and biocompatibility of the flap valve 14.
[0037] Specifically, the design of the flap valve can control the drainage speed of the aqueous humor, avoiding low intraocular pressure caused by too fast drainage or too high intraocular pressure caused by too slow drainage. It can also reduce complications caused by displacement or detachment of the drainage tube, thereby extending the service life of the minimally invasive ophthalmic drainage implant device.
[0038] Specifically, the identification support ring 2 is configured as a ring or a woven mesh with a fluorescent color.
[0039] Specifically, the identification support ring can be made of a material with fluorescent properties, such as a polymer containing a fluorescent dye. This material is able to emit light under a specific wavelength of light, thereby providing a clear visual indication under a surgical microscope. The identification support ring can be designed as a ring structure to facilitate fixation in the appropriate position of the drainage tube. The diameter and thickness of the ring should be determined according to the size and shape of the drainage tube to ensure that the ring can be stably fixed on the drainage tube. In addition to the ring, the identification support ring can also be designed as a woven mesh. This design can provide a larger surface area and increase the distribution of the fluorescent material, thereby producing a stronger fluorescent effect under light irradiation.
[0040] Specifically, fluorescent marking makes the surgery more precise and reduces the risk of patients undergoing secondary surgery because the drainage tube can be placed and confirmed more accurately. Fluorescent marking makes it easier to identify and locate the entrance of the drainage tube during surgery, simplifying the surgical steps and reducing the surgical time.
[0041] Specifically, when the main control determines that the real-time pressure is greater than the standard pressure, it controls the drainage chamber to drain at a preset drainage speed, and repeats the above process by obtaining the real-time flow and the real-time pressure of the diversion positioning end, and making a judgment based on the standard pressure and the real-time pressure. If it is determined that the real-time pressure is less than or equal to the standard pressure, the main control controls the drainage chamber to maintain the current drainage speed.
[0042] Specifically, before the operation, a standard pressure value is set according to the patient's specific conditions and surgical requirements. The standard pressure is determined based on factors such as the patient's intraocular pressure, anterior chamber depth, and the elasticity of the eyeball wall. This value will be used as a reference standard, and the general value range is 5-25 millibars (1 millibar = 100 Pa). The standard pressure in this embodiment is 15 millibars, which is used for comparison with the real-time pressure.
[0043] Specifically, during the operation, the main control monitors the real-time pressure through the pressure sensor connected to the diversion positioning end. The main control compares the monitored real-time pressure with the set standard pressure. If the real-time pressure is greater than the standard value, it means that there may be too fast or too much drainage. Since the real-time pressure is greater than the standard pressure, the main control will control the drainage cavity to drain at a preset drainage speed. This preset drainage speed is a value that has been calculated and experimentally verified, which can ensure safe and effective drainage under excessive pressure. The main control will continue to monitor the real-time flow and real-time pressure of the diversion positioning end. After each monitoring, the main control will re-determine whether the real-time pressure is less than or equal to the standard pressure. If the main control determines that the real-time pressure is less than or equal to the standard pressure, it will control the drainage cavity to maintain the current drainage speed. If the real-time pressure exceeds the standard value again, the main control will continue to control the drainage cavity to drain at a preset speed (for example, 10 drops per minute). Throughout the operation, the main control will continuously receive data from the pressure sensor and flow sensor, and make real-time adjustments based on these data.
[0044] Specifically, by real-time monitoring and adjusting the drainage pressure, it is possible to ensure that the drainage process is carried out efficiently and avoid excessive fluid accumulation or too rapid fluid outflow. Too high pressure may cause damage to intraocular tissue, while too low pressure may lead to poor drainage. Real-time adjustment can avoid these risks and reduce the occurrence of complications. By maintaining a stable drainage speed, the intraocular pressure can be kept stable.
[0045] Specifically, when the main control determines that the real-time flow rate is greater than the standard flow rate, the real-time drainage speed of the drainage cavity is obtained, and the main control adjusts the real-time drainage speed according to the real-time flow rate to obtain a corrected drainage speed, wherein Q'=Q×[1-(C-C1) / C], Q' is the corrected drainage speed, Q is the real-time drainage speed of the drainage cavity obtained, C is the real-time flow obtained by the flow sensor, and C1 represents the set standard flow rate.
[0046] Specifically, first, according to the needs of the operation and the specific conditions of the patient, a standard flow rate will be set, such as 15 drops per minute. During the operation, the flow sensor will monitor the flow of the drainage cavity in real time and send the data to the main control. After receiving the information from the flow sensor, the main control calculates the real-time drainage speed of the drainage cavity, such as 18 drops per minute. The main control compares the real-time flow rate with the standard flow rate. If the real-time flow rate is greater than the standard flow rate, for example, the actual flow rate is 20 drops per minute, which is greater than the set 15 drops per minute, the adjustment mechanism is triggered. The main control adjusts the real-time drainage speed according to the real-time flow rate, and uses the formula Q'=Q×[1-(C-C1 / C] to calculate the corrected drainage speed. Q is the real-time drainage speed (18 drops / minute), C is the real-time flow rate (20 drops / minute), and C1 is the standard flow rate (15 drops / minute). Substitute the values into the formula: Q'=18×[1-(20-15) / 20]≈14 drops / minute.
[0047] Specifically, when the real-time flow rate exceeds the standard flow rate, the master control reduces the drainage speed to prevent intraocular fluid accumulation or excessive drainage, thereby reducing the risk of complications. Precise control of the drainage speed helps optimize surgical outcomes, reduce postoperative complications, and improve patients' visual recovery. By improving surgical efficiency and reducing complications, medical costs can be reduced. A stable drainage speed can reduce patient discomfort and improve the patient's overall comfort.
[0048] Specifically, the preset curvature of the stable discharge end makes the curvature of the stable discharge end the same as the curvature of the eye.
[0049] Specifically, the curvature of the patient's eye is measured before surgery using specialized eye curvature measurement equipment, such as corneal topography. This helps determine the natural curvature of the eye and ensures that the curvature of the stabilizing discharge tip matches it. Based on the eye curvature measurement, the preset curvature of the stabilizing discharge tip is designed. Ensure that the material of the stabilizing discharge tip has good flexibility and plasticity so that it can adapt to the curvature of the eye during implantation. Manufacture the stabilizing discharge tip according to the design, ensuring that its preset curvature matches the curvature of the eye. The manufacturing process may require the use of thermoplastic materials and heat treatment to bend them, or the use of elastic materials so that they can adjust their curvature during implantation.
[0050] Specifically, the stable discharge end matches the curvature of the eye, reducing discomfort during the implantation process and the sense of pressure on the patient's eyes after implantation, thereby improving the patient's comfort.
[0051] Specifically, one end of the drainage cavity is connected to the diversion positioning end, and a first inner wall ring groove, a second inner wall ring groove, a third inner wall ring groove, a fourth inner wall ring groove and a fifth inner wall ring groove are arranged in sequence from far to near, and the spacing between each inner wall ring groove and the depth of each inner wall ring groove can be adjusted to control the back pressure by adjusting the drainage speed.
[0052] Specifically, the spacing between the first inner wall groove and the second inner groove is in the range of [20, 40], and the depth of the first inner wall groove is in the range of (0, 20]; the spacing between the second inner wall groove and the third inner wall groove is in the range of [20, 60], and the depth of the second inner groove is in the range of (0, 40]; the spacing between the third inner wall groove and the fourth inner wall groove is in the range of [20, 80], and the depth of the third inner wall groove is in the range of (0, 60]; the spacing between the fourth inner wall groove and the fifth inner wall groove is in the range of [20, 100], the depth of the fourth inner wall groove is in the range of (0, 100], and the depth of the fifth inner wall groove is in the range of (0, 120], and the units of the above spacings and depths are all in micrometers, which can be set by those skilled in the art according to actual conditions.
[0053] Specifically, one end of the drainage cavity is connected to the diversion positioning end. By setting a plurality of inner wall ring grooves, precise control of the drainage speed can be achieved, thereby achieving precise control of the back pressure. The first inner wall ring groove to the fifth inner wall ring groove are arranged in sequence from far to near, which can gradually reduce the drainage speed and then gradually reduce the back pressure, which helps to adapt to different drainage needs. The spacing and depth of each inner wall ring groove are adjustable, providing greater flexibility. The inner wall ring grooves can be set to 1-5 according to actual needs, and the spacing and groove depth are adjusted according to actual needs. The doctor can adjust according to the specific situation of the patient and the drainage effect to achieve the best drainage effect. By adjusting the spacing and depth of the inner wall ring grooves, the drainage speed can be effectively controlled to avoid complications caused by too fast or too slow drainage, such as hypotension or electrolyte imbalance caused by excessive drainage. The design of the inner wall ring groove helps to reduce the friction and resistance of the drainage tube, reduce the risk of clogging of the drainage tube, and extend the service life of the drainage tube.
[0054] Specifically, if Figure 3 As shown, the outer wall of the stable discharge end 3 is also provided with a plurality of drug-carrying micropores 6, and the channels of the drug-carrying micropores 6 are circular, square or polygonal.
[0055] Specifically, the shape of the micropores can be circular, square or polygonal, depending on the manufacturing process and the requirements of drug release. For example, circular micropores may be easier to manufacture, while square or polygonal micropores may help distribute the drug more evenly. The diameter of the micropores is usually smaller than the inner diameter of the drainage tube to ensure that the drug can enter the drainage cavity smoothly. For example, the diameter of the micropores can be 20-50 microns. The micropores can be evenly distributed on the outer wall of the stable discharge end to ensure that the drug can be evenly released into the drainage cavity. The number of micropores can be determined according to the needs of the drug and the expected therapeutic effect. For example, 5-20 micropores can be set. The depth of the micropores needs to be sufficient to allow the drug to be stored therein, but not too deep so as not to affect the structural stability of the stable discharge end. For example, the depth of the micropores can be 10-50 microns. Different drugs can be selected to be loaded into the micropores, such as antibiotics, anti-inflammatory drugs, cytokines, etc., to meet different therapeutic needs. The drug can be loaded into the micropores by methods such as solution immersion, spraying or pressure filling.
[0056] Specifically, through drug-loaded micropores, drugs can be released directly into the drainage cavity to achieve the purpose of local drug administration, reduce the circulation and distribution of drugs in the body, and thus reduce systemic side effects. The shape, size and distribution of drug-loaded micropores can accurately control the release rate and duration of drugs, making drug release more stable and predictable. Through local administration, drugs can act directly on the lesion site, improve treatment efficiency and speed up the recovery process. The shape of drug-loaded micropores can be circular, square or polygonal, providing more design options and flexibility to accommodate different drugs and treatment needs.
[0057] Specifically, the drug-loaded micropore cooperates with the inner wall annular groove, and the drainage speed is adjusted by changing the cooperation state, wherein the drug-loaded micropore runs through the stable discharge end and is used to assist in the sustained release of the drug loaded therein, and the inner wall annular groove is used to interact with the drug-loaded micropore to adjust the release rate and drainage speed of the drug.
[0058] Specifically, the drug to be treated is loaded into the drug-loaded micropores. The drainage speed is adjusted by changing the matching state between the drug-loaded micropores and the inner wall annular grooves. For example, the drainage cavity 4 with the inner wall annular groove 41 is made of a soft material (such as a rubber material) that can undergo plastic deformation, and then the depth, width or shape of the inner wall annular groove can be adjusted by extrusion and stretching to make it elongated or flattened, thereby changing its interaction with the drug-loaded micropores. The ophthalmic minimally invasive drainage implant device is implanted into the patient's eye, with the stable discharge end located in the eye and the guide drainage end facing outside the eye. After implantation, the drug in the drug-loaded micropores begins to be slowly released into the eye through the regulating effect of the inner wall annular groove. At the same time, the excess fluid in the eye is discharged outside the eye through the guide drainage end, achieving minimally invasive drainage.
[0059] Specifically, by changing the matching state of the drug-carrying micropores and the inner wall annular grooves, the drainage speed can be adjusted to achieve the purpose of treating glaucoma or other eye diseases.
[0060] Specifically, if Figure 5 As shown, the ophthalmic minimally invasive drainage implant device described in this embodiment can be integrally arranged in a delivery device and cooperate with the delivery device for treatment. The delivery device has a built-in puncture needle and ejector pin 42, and a liner core 43 is provided in the drainage cavity.
[0061] Specifically, the drainage tube is preset in the scleral puncture needle of the delivery system, the drainage positioning end is at the distal end, the proximal end of the drainage tube is abutted by the ejector pin, and the tube is supported and fixed in position by a liner core. At a distance of 4.0-6.0 mm from the limbus, preferably 4.5-5.0 mm, the puncture needle is inserted through the sclera into the suprachoroidal space (it can be injected through the suprachoroidal space syringe first), and the viscoelastic agent is injected into the suprachoroidal space to stretch it open so that the puncture needle can accurately locate the puncture), and then the drainage tube is pushed out of the puncture needle by controlling the ejector pin, and the drainage cavity supported by the liner core is sent into the suprachoroidal space and pushed to the limbus. The placement of the drainage tube is determined by observing whether the marking ring on the head of the drainage tube enters the anterior chamber angle. Once the drainage tube is in place, the liner core is controlled to withdraw and release the drainage tube, and the ejector pin does not move to ensure accurate positioning, and then the delivery system is withdrawn as a whole to complete the drainage tube implantation process.
[0062] Specifically, the detachability of the ejector pin and the liner makes the drainage tube more flexible during implantation. The doctor can easily adjust the position of the drainage tube according to the specific circumstances of the operation to ensure that it accurately reaches the intended drainage area. The detachable design allows for more precise control of the implantation depth and direction of the drainage tube, thereby reducing the risk of damaging surrounding tissues and reducing the occurrence of complications.
[0063] So far, the technical solutions of the present invention have been described in conjunction with the preferred embodiments shown in the accompanying drawings. However, it is easy for those skilled in the art to understand that the protection scope of the present invention is obviously not limited to these specific embodiments. Without departing from the principle of the present invention, those skilled in the art can make equivalent changes or substitutions to the relevant technical features, and the technical solutions after these changes or substitutions will fall within the protection scope of the present invention.
[0064] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. An ophthalmic minimally invasive drainage implant device, characterized in that: It includes a diversion positioning end, a marking support ring, a stable discharge end, a diversion cavity and a main control; The diversion positioning end has a head provided with a positioning groove, a pressure sensor for monitoring pressure, and a flow sensor for monitoring flow, and the positioning groove is used to locate the head position of the diversion positioning end; The identification support ring is located below the positioning groove and embedded in the groove wall, and is used to support the shape of the tube orifice and determine the position of the tube orifice during implantation; The stable discharge end has a plurality of retaining rings symmetrically arranged on the top and bottom thereof, and the retaining rings are used to fix the position of the drainage tube; The main control is arranged on the stable discharge end, and the main control can obtain the real-time flow of the flow sensor and the real-time pressure of the pressure sensor and make a judgment; When it is determined that the real-time flow rate is less than or equal to the standard flow rate and the real-time pressure is less than or equal to the standard pressure, the current drainage speed is maintained; when it is determined that the real-time flow rate is greater than the standard flow rate, the drainage speed of the drainage cavity is adjusted to a corrected drainage speed; The drainage cavity is horizontally arranged at the center of the stable discharge end, and is symmetrically provided with inner wall ring grooves matching the number of the retaining rings. The inner wall ring grooves regulate the back pressure by regulating the drainage speed.
2. The ophthalmic minimally invasive drainage implant device according to claim 1, characterized in that: The flow guiding and positioning end further comprises a flap valve arranged inside the flow guiding and positioning end, a cross or straight opening is arranged on the top of the flap valve, and a bottom diameter of the flap valve is larger than a top diameter of the flap valve.
3. The ophthalmic minimally invasive drainage implant device according to claim 2, characterized in that: The identification support ring is configured as a ring-shaped object or a woven mesh object with a fluorescent color system.
4. The ophthalmic minimally invasive drainage implant device according to claim 3, characterized in that: When the main control determines that the real-time pressure is greater than the standard pressure, the main control controls the drainage chamber to drain at a preset drainage speed, and repeatedly obtains the real-time flow and the real-time pressure of the diversion positioning end, and makes a judgment based on the standard pressure and the real-time pressure. If it is determined that the real-time pressure is less than or equal to the standard pressure, the main control controls the drainage chamber to maintain the current drainage speed.
5. The ophthalmic minimally invasive drainage implant device according to claim 4, characterized in that: When the main control determines that the real-time flow rate is greater than the standard flow rate, the real-time drainage speed of the drainage cavity is obtained, and the main control adjusts the real-time drainage speed according to the real-time flow rate to obtain a corrected drainage speed, wherein Q'=Q×[1-(C-C1) / C], Q' is the corrected drainage speed, Q is the real-time drainage speed of the drainage cavity obtained, C is the real-time flow obtained by the flow sensor, and C1 represents the set standard flow rate.
6. The ophthalmic minimally invasive drainage implant device according to claim 5, characterized in that: The preset curvature of the stable discharge end makes the curvature of the stable discharge end the same as the curvature of the eye.
7. The ophthalmic minimally invasive drainage implant device according to claim 6, characterized in that: One end of the drainage cavity is connected to the diversion positioning end, and a first inner wall ring groove, a second inner wall ring groove, a third inner wall ring groove, a fourth inner wall ring groove and a fifth inner wall ring groove are sequentially arranged, and the spacing between each inner wall ring groove and the depth of each inner wall ring groove can be adjusted to control the back pressure by adjusting the drainage speed.
8. The ophthalmic minimally invasive drainage implant device according to claim 7, characterized in that: The outer wall of the stable discharge end is also provided with a plurality of drug-carrying micropores, and the pores of the drug-carrying micropores are circular, square or polygonal.
9. The ophthalmic minimally invasive drainage implant device according to claim 8, characterized in that: The drug-loaded micropore cooperates with the inner wall annular groove, and the drainage speed is adjusted by changing the cooperation state, wherein the drug-loaded micropore runs through the stable discharge end and is used to assist in the sustained release of the drug loaded therein, and the inner wall annular groove is used to interact with the drug-loaded micropore to adjust the release rate and drainage speed of the drug.
10. The ophthalmic minimally invasive drainage implant device according to claim 9, characterized in that: The drainage implantation device cooperates with a delivery device, the delivery device has a built-in puncture needle and an ejector pin, and a lining core is arranged in the drainage cavity.
Citation Information
Cited By
Minimally invasive implantable ophthalmic drainage device and delivery system thereof
WO2026001957A1
